Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
GlucoModicum Oy
OY
Active
Y-tunnus 2900506-7
Toinen Linja 7, 00530
Helsinki
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
— employees
wwww.glucomodicum.com
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
GlucoModicum Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
-1M
-3M
-4M
-5M
-1M
2021
-1M
0%
2022
-2M
-100%
2023
-3M
-50%
2024
-4M
-33%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
−562
−891
−1 189
−1 409
−1 764
EBITDA
−1 223
−1 037
−2 492
−3 328
−3 960
Depreciation & amort.
−671
−836
−1 737
−1 663
−2 607
EBIT
−1 894
−1 873
−4 228
−4 992
−6 567
Net financials
−36
−57
−55
98
−203
Profit before tax
−1 930
−1 930
4 284
−4 894
−6 769
Tax
−0
−0
−0
−0
−0
Net profit
−1 930
−1 930
4 284
−4 894
−6 769
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
9 757
8 641
18 439
14 761
16 767
Equity
7 670
5 740
12 508
7 693
8 062
Long-term debt
1 519
2 073
4 902
6 059
7 471
Short-term debt
567
827
1 029
1 008
1 234
Total debt
2 087
2 901
5 932
7 067
8 705
Financial ratios
5-year trend
EBITDA-margin
-395974500.0%
This company
15.8%
Market median
-2506167822% vs market
2021
2025
Soliditetsgrad
48.1%
This company
38.2%
Market median
+26% vs market
2021
2025
Egenkapitalforrentning
-84.0%
This company
18.4%
Market median
-557% vs market
2021
2025
Nettoresultatgrad
-676933100.0%
This company
8.1%
Market median
-8357198865% vs market
2021
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Gæld/egenkapital
1.08×
This company
0.62×
Market median
-74% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on GlucoModicum Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
